Chemical Compound
Eltrombopag olamine
CAS Registry Number
496775-62-3
Primary Record
Eltrombopag olamine
- In stock
- 5,845 g
- Purity
- 98.4 %
- CAS
- 496775-62-3
Compound Identifiers & Properties
- CAS
- 496775-62-3
- PubChem CID
- 135449331
- SMILES
- CC1=C(C=C(C=C1)N2C(=O)C(=C(N2)C)N=NC3=CC=CC(=C3O)C4=CC(=CC=C4)C(=O)O)C.C(CO)N.C(CO)N
- Canonical SMILES
- Cc1ccc(-n2[nH]c(C)c(N=Nc3cccc(-c4cccc(C(=O)O)c4)c3O)c2=O)cc1C.NCCO.NCCO
Names & Synonyms
- Eltrombopag olamine
- Promacta
- Revolade
- 496775-62-3
- Eltrombopag (Olamine)
- 2-aminoethanol
- UNII-4U07F515LG
- Eltrombopagolamine
- Promacta (TN)
- Eltrombopag olamine?
- Eltrombopag (as olamine)
- EltroMbopag diethanolaMine salt
- SB-497115-GR
- 496775-62-3 (olamine)
- Eltrombopag olamine [USAN:JAN]
- Eltrombopag Olamine [USAN]
- SCHEMBL210183
- MFCD22380664
- 4U07F515LG
- AMY267
- orb1300431
- CHEMBL3989691
- SCHEMBL16207741
- SCHEMBL23458316
- SCHEMBL29386642
- SCHEMBL29452757
- Eltrombopag olamine (JAN/USAN)
- SB 497115GR
- ELTROMBOPAG OLAMINE [JAN]
- CHEBI:234330
- Eltrombopag (Olamine) (Standard)
- PLILLUUXAVKBPY-SBIAVEDLSA-N
- C29H36N6O6
- ELTROMBOPAG OLAMINE [USAN]
- GLXC-06920
- HMS5080A20
- HY-15306AR
- BCP07055
- C25H22N4O4.2C2H7NO
- Eltrombopag (SB497115) Olamine
- ELTROMBOPAG OLAMINE [MART.]
- SB-497115GR
- 3608AH
- ELTROMBOPAG OLAMINE [WHO-DD]
- HY-15306A
- MFCD30181471
- s2229
- AKOS025396658
- AKOS037515856
- CCG-270074
- CID9915926
- CS-1566
- SB19102
- CID 9915926
- ELTROMBOPAG OLAMINE [ORANGE BOOK]
- AC-26286
- BS-17370
- Eltrombopag compd with 2-aminoethanol (1:2)
- Eltrombopag diethanolamine salt;SB-497115GR
- FD157443
- PD087725
- SY046957
- SB-497115
- A3387
- FT-0773802
- A15078
- D03978
- Z-3296
- C25-H22-N4-O4.2(C2-H7-N-O)
- Q27260489
- ELTROMBOPAG COMPD WITH 2-AMINOETHANOL (1:2) [MI]
- (Z)-3'-(2-(1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydro-4H-pyrazol-4-ylidene)hydrazinyl)-2'-hydroxy-[1,1'-biphenyl]-3-carboxyiic acid;2-aminoethan-1-ol (1:2)
- 2-aminoethanol;3-[3-[[2-(3,4-dimethylphenyl)-5-methyl-3-oxo-1H-pyrazol-4-yl]diazenyl]-2-hydroxyphenyl]benzoic acid
- 3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
- (1,1'-Biphenyl)-3-carboxylic acid, 3'-((2Z)-(1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene)hydrazino)-2'-hydroxy, compound with 2-Aminoethanol (1:2)
- (Z)-3 inverted exclamation mark -[2-[1-(3,4-Dimethylphenyl)-3-methyl-5-oxopyrazol-4(5H)-ylidene]hydrazino]-2 inverted exclamation mark -hydroxybiphenyl-3-carboxylic Acid compd. with 2-Aminoethanol (1:2)
- [1,1'-Biphenyl]-3-carboxylic acid, 3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-, compd. with 2-aminoethanol (1:2)
- [1,1'-Biphenyl]-3-carboxylic acid, 3'-[(2Z)-2-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazinyl]-2'-hydroxy-, compd. with 2-aminoethanol (1:2)
- [1,1'-Biphenyl]-3-carboxylic acid, 3'-[(2Z)-2-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazinyl]-2'-hydroxy-, compd. with 2-aminoethanol (1:2); [1,1'-Biphenyl]-3-carboxylic acid, 3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-, compd. with 2-aminoethanol (1:2) (9CI); Eltrombopag diethanolamine salt; Eltrombopag olamine; Promacta; Revolade; SB 497115GR; SB-497115GR; SB497115GR Test Mix 1; SB497115GR
- [1,1'-Biphenyl]-3-carboxylic acid, 3'-[2-[1-(3,4-dimethylphenyl)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-4-yl]diazenyl]-2'-hydroxy-, compd. with 2-aminoethanol (1:2)
- 2-aminoethan-1-ol hemi((E)-3'-(2-(2-(3,4-dimethylphenyl)-5-methyl-3-oxo-2,3-dihydro-1H-pyrazol-4-yl)hydrazono)-2'-oxo-2',3'-dihydro-[1,1'-biphenyl]-3-carboxylate)
- 2-aminoethan-1-ol hemi((Z)-3'-(2-(1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydro-4H-pyrazol-4-ylidene)hydrazineyl)-2'-hydroxy-[1,1'-biphenyl]-3-carboxylate)
- 2-Aminoethan-1-ol hemi((Z)-3'-(2-(1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydro-4H-pyrazol-4-ylidene)hydrazinyl)-2'-hydroxy-[1,1'-biphenyl]-3-carboxylate)
- 2-Aminoethanol (E)-3'-(2-(1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1H-pyrazol-4(5H)-ylidene)hydrazinyl)-2'-hydroxy-[1,1'-biphenyl]-3-carboxylate
- 2-aminoethanol;3-[(5E)-5-[[2-(3,4-dimethylphenyl)-5-methyl-3-oxo-1H-pyrazol-4-yl]hydrazinylidene]-6-oxocyclohexa-1,3-dien-1-yl]benzoic acid
- 2-aminoethanol;3-[3-[[2-(3,4-dimethylphenyl)-5-methyl-3-oxo-1H-pyrazol-4-yl]azo]-2-hydroxy-phenyl]benzoic acid
- 3'-((2Z)-2-(1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1,5-dihydro-4H-pyrazol-4-ylidene)diazanyl)-2'-hydroxybiphenyl-3-carboxylic acid compound with 2-aminoethanol (1:2)
- 3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
- 3'-[(2Z)-2-[1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydro-4H-pyrazol-4-ylidene]diazanyl]-2'-hydroxybiphenyl-3-carboxylic acid compound with 2-aminoethanol (1:2)
- 3-[(5E)-5-{2-[1-(3,4-DIMETHYLPHENYL)-3-METHYL-5-OXO-2H-PYRAZOL-4-YL]HYDRAZIN-1-YLIDENE}-6-OXOCYCLOHEXA-1,3-DIEN-1-YL]BENZOIC ACID; BIS(ETHANOLAMINE)
- 3-[3-[[2-(3,4-dimethylphenyl)-5-methyl-3-oxo-1H-pyrazol-4-yl]diazenyl]-2-hydroxyphenyl]benzoic acid